The concentrations of HDL-associated serum amyloid A ( SAA ) and surfactant protein B ( SP-B ) were measured in 1152 patients with type 2 diabetes mellitus on hemodialysis participating in The German Diabetes Dialysis Study who were randomly assigned to double-blind treatment of 20 mg atorvastatin daily or matching placebo .